Postmenopausal Period Completed Phase Trials for Estradiol (DB00783)

IndicationStatusPhase
DBCOND0046410 (Postmenopausal Period)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01064453Angeliq Regulatory Post Marketing Surveillance